Are We Overlooking Harms of BDDE-Cross-Linked Dermal Fillers? A Scoping Review
Authors:
Open Access
- 6 August 2024
- journal article
- review article
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 48 (23) , 5147-5154
Abstract
1,4-Butanediol ether (BDDE) is widely used as a cross-linker for hyaluronic acid in dermal fillers. The purpose of this scoping review was to determine the state of knowledge about the behaviour of cross-linked substances and safety of BDDE application. The rationale behind the review came from the clinical experience of one of the authors (KS), who noticed adverse reactions after BDDE-linked hyaluronan application. The scoping review was conducted according to PRISMA-ScR guidelines. Out of 399 articles, 52 met the inclusion criteria. Data on study design, sample/population, aims, methodology, outcomes and funding were extracted. Results were charted according to 6 subtopics: rheological properties, hydrogel stability, BDDE toxicity, immunogenicity, tissue interactions and clinical studies. In vitro, cross-linked hydrogels were characterized as effective fillers in terms of viscosity and elasticity; however, previously uncharacterized by-products of the cross-linking reaction were found. Most in vivo studies reported increased dermis regeneration, vascularization and anti-inflammatory cytokine release after implantation of BDDE-cross-linked substances. In clinical studies, BDDE was shown to sensitize subjects to 1,6-hexanediol ether and other substances found in epoxy resin systems. Occupational dermatitis and hypersensitivity reactions were documented. Our review shows that BDDE may have long-term adverse effects, which are overlooked in the safety assessment of fillers. Reviews on BDDE conducted so far have mostly been sponsored by the industry, potentially leading to incomplete reporting of adverse effects. A review of the occurrence of allergic reactions after commercial dermal filler use and analysis of possibly harmful by-products of BDDE hyaluronan degradation are needed. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.Keywords
This publication has 46 references indexed in Scilit:
- A covalently cross-linked hyaluronic acid/bacterial cellulose composite hydrogel for potential biological applicationsCarbohydrate Polymers, 2021
- Relaxation and diffusion of water protons in BDDE cross-linked hyaluronic acid hydrogels investigated by NMR spectroscopy—Comparison with physicochemical propertiesCarbohydrate Polymers, 2020
- Facile strategy involving low-temperature chemical cross-linking to enhance the physical and biological properties of hyaluronic acid hydrogelCarbohydrate Polymers, 2018
- Development of a BDDE-crosslinked hyaluronic acid based microneedles patch as a dermal filler for anti-ageing treatmentJournal of Industrial and Engineering Chemistry, 2018
- In situ crosslinked electrospun gelatin nanofibers for skin regenerationEuropean Polymer Journal, 2017
- Comparative histologic and immunologic evaluation of 1,4-butanediol diglycidyl ether crosslinked versus noncrosslinked acellular swim bladder matrix for healing of full-thickness skin wounds in rabbitsJournal of Surgical Research, 2015
- Modulation of biomechanical properties of hyaluronic acid hydrogels by crosslinking agentsJournal of Biomedical Materials Research Part A, 2015
- Investigation into the safety of perineural application of 1,4‐butanediol diglycidyl ether‐crosslinked hyaluronan in a rat modelJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2014
- Improvement of hyaluronic acid enzymatic stability by the grafting of amino-acidsCarbohydrate Polymers, 2012
- Chemical mutagenesis testing in Drosophila. IX. Results of 50 coded compounds tested for the national toxicology programEnvironmental and Molecular Mutagenesis, 1994